ResearchHub Endowment
Earn daily Funding Credits to fund science
Paper
Paper
Search
Search
Log in
Sign up
Sign up
Publish
Home
Fund
Earn
Journal
Endowment
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Search
Search
Hydroxychloroquine in patients mainly with mild to modera... | ResearchHub
ResearchHub Endowment
Earn daily Funding Credits to fund science
Paper
Paper
Search
Search
Log in
Sign up
Sign up
Publish
Home
Fund
Earn
Journal
Endowment
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial
5
Paper
Reviews
0
Conversation
0
Bounties
0
Search
Search
Loading PDF viewer…
Topics
#medicine
#covid-19-coronavirus
Other Formats
PDF
